| Open Document File Size: 54,67 KBShare Result on Facebook
Company LA Times / FDA Press / Fentanyl Transdermal Systems / Reuters / / IndustryTerm opiate drug products / drug product / opioid drug product / healthcare providers / drug products / / MedicalCondition behavioral disorder / cancers / serious diseases / serious chronic painful conditions / cancer / headache / chronic pain / chronic opiates / chronic painful conditions / chronic painful disorders / terminal cancer / pain / terminal disease / respiratory depression / illness / / MedicalTreatment surgery / / Organization U.S. Food and Drug Administration / Institute for Safe Medication Practices / / Person Lauren Neergaard / Christopher Kelly / Ricardo Alonso-Zaldivar / Lisa Richwine / Bob Rappaport / / / Position CT Coordinator / Director of the Division / Coordinator / pharmacist / / Product Safe Medication / Duragesic / Fentanyl / Fentora / / PublishedMedium the archives of Internal Medicine / / Technology pharmacokinetics / /
SocialTag |
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may